388 related articles for article (PubMed ID: 31342441)
1. RNA Therapeutics: How Far Have We Gone?
Coutinho MF; Matos L; Santos JI; Alves S
Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
[TBL] [Abstract][Full Text] [Related]
2. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC; Kowalski PS; Anderson DG
Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
[TBL] [Abstract][Full Text] [Related]
3. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
4. Innovative developments and emerging technologies in RNA therapeutics.
Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
[TBL] [Abstract][Full Text] [Related]
5. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases.
Pandey M; Ojha D; Bansal S; Rode AB; Chawla G
Mol Aspects Med; 2021 Oct; 81():101003. PubMed ID: 34332771
[TBL] [Abstract][Full Text] [Related]
6. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
7. The infinite possibilities of RNA therapeutics.
Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
[TBL] [Abstract][Full Text] [Related]
8. Splice-switching antisense oligonucleotides as therapeutic drugs.
Havens MA; Hastings ML
Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
[TBL] [Abstract][Full Text] [Related]
9. RNA-based therapies for genodermatoses.
Bornert O; Peking P; Bremer J; Koller U; van den Akker PC; Aartsma-Rus A; Pasmooij AM; Murauer EM; Nyström A
Exp Dermatol; 2017 Jan; 26(1):3-10. PubMed ID: 27376675
[TBL] [Abstract][Full Text] [Related]
10. RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger B; Piñón Hofbauer J; Wally V; Arzt C; Hainzl S; Kocher T; Murauer EM; Bauer JW; Reichelt J; Koller U
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518954
[TBL] [Abstract][Full Text] [Related]
11. The notorious R.N.A. in the spotlight - drug or target for the treatment of disease.
Reautschnig P; Vogel P; Stafforst T
RNA Biol; 2017 May; 14(5):651-668. PubMed ID: 27415589
[TBL] [Abstract][Full Text] [Related]
12. Tissue-Specific Delivery of Oligonucleotides.
Xia X; Pollock N; Zhou J; Rossi J
Methods Mol Biol; 2019; 2036():17-50. PubMed ID: 31410789
[TBL] [Abstract][Full Text] [Related]
13. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
14. Antisense-mediated redirection of mRNA splicing.
Vacek M; Sazani P; Kole R
Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
[TBL] [Abstract][Full Text] [Related]
15. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
[TBL] [Abstract][Full Text] [Related]
16. Current RNA-based Therapeutics in Clinical Trials.
Zhou LY; Qin Z; Zhu YH; He ZY; Xu T
Curr Gene Ther; 2019; 19(3):172-196. PubMed ID: 31566126
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress and prospect in oligonucleotide therapeutics].
Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
[TBL] [Abstract][Full Text] [Related]
18. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
19. Types of RNA therapeutics.
Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
[TBL] [Abstract][Full Text] [Related]
20. RNA-targeted therapeutics in cardiovascular disease: the time is now.
Krychtiuk KA; Rader DJ; Granger CB
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):94-99. PubMed ID: 36138490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]